S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
BAC   34.12 (-0.70%)
DIS   142.18 (-1.27%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
BAC   34.12 (-0.70%)
DIS   142.18 (-1.27%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
BAC   34.12 (-0.70%)
DIS   142.18 (-1.27%)
GILD   63.94 (+0.80%)
S&P 500   3,325.54 (+0.11%)
DOW   29,160.09 (-0.09%)
QQQ   224.59 (+0.32%)
AAPL   319.23 (+0.48%)
FB   219.76 (-0.70%)
MSFT   166.72 (+0.62%)
GOOGL   1,484.69 (+0.04%)
AMZN   1,884.58 (-0.15%)
CGC   24.56 (+1.82%)
NVDA   252.86 (+1.12%)
BABA   219.13 (-1.46%)
MU   59.20 (+0.05%)
GE   11.77 (+3.52%)
TSLA   572.20 (+0.46%)
AMD   51.71 (+0.54%)
T   38.63 (-1.05%)
ACB   2.07 (+1.47%)
F   9.14 (-0.22%)
BAC   34.12 (-0.70%)
DIS   142.18 (-1.27%)
GILD   63.94 (+0.80%)
Log in
(Ad)
If you're looking to potentially make 1,000% in gains, then you NEED this biotech stock. This company discovered a medical breakthrough that may end heart attacks FOREVER! Estimated annual sales are $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, the stock price could double overnight. But you must be onboard BEFORE FDA approval.

NASDAQ:TVTY - Tivity Health Stock Price, Forecast & News

$24.60
-0.13 (-0.53 %)
(As of 01/23/2020 04:00 PM ET)
Add
Compare
Today's Range
$24.39
Now: $24.60▼
$25.05
50-Day Range
$19.27
MA: $21.47▼
$25.85
52-Week Range
$14.84
Now: $24.60▼
$26.07
Volume33,475 shs
Average Volume673,608 shs
Market Capitalization$1.18 billion
P/E Ratio17.20
Dividend YieldN/A
Beta1.16
Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers. It also provides health plans through WholeHealth Living program; and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. Read More…

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryHealth Care Services
SectorMedical
Current SymbolNASDAQ:TVTY
Previous Symbol
CUSIP42224510
CIK704415
Webhttp://www.tivityhealth.com/
Phone800-869-5311

Debt

Debt-to-Equity Ratio1.96
Current Ratio0.94
Quick Ratio0.78

Price-To-Earnings

Trailing P/E Ratio17.20
Forward P/E Ratio11.34
P/E Growth1.13

Sales & Book Value

Annual Sales$606.30 million
Price / Sales1.95
Cash Flow$2.69 per share
Price / Cash Flow9.16
Book Value$9.17 per share
Price / Book2.68

Profitability

EPS (Most Recent Fiscal Year)$2.34
Net Income$98.80 million
Net Margins6.41%
Return on Equity21.67%
Return on Assets6.46%

Miscellaneous

Employees500
Outstanding Shares47,990,000
Market Cap$1.18 billion
Next Earnings Date2/18/2020 (Estimated)
OptionableOptionable

Receive TVTY News and Ratings via Email

Sign-up to receive the latest news and ratings for TVTY and its competitors with MarketBeat's FREE daily newsletter.

NASDAQ:TVTY Rates by TradingView

(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

Tivity Health (NASDAQ:TVTY) Frequently Asked Questions

What is Tivity Health's stock symbol?

Tivity Health trades on the NASDAQ under the ticker symbol "TVTY."

How were Tivity Health's earnings last quarter?

Tivity Health Inc (NASDAQ:TVTY) posted its quarterly earnings data on Tuesday, November, 12th. The company reported $0.46 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.56 by $0.10. The firm earned $303.90 million during the quarter, compared to analysts' expectations of $301.52 million. Tivity Health had a net margin of 6.41% and a return on equity of 21.67%. The company's quarterly revenue was up 100.6% on a year-over-year basis. During the same quarter last year, the business posted $0.59 EPS. View Tivity Health's Earnings History.

When is Tivity Health's next earnings date?

Tivity Health is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for Tivity Health.

What guidance has Tivity Health issued on next quarter's earnings?

Tivity Health issued an update on its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of $2.14-2.32 for the period, compared to the Thomson Reuters consensus estimate of $2.21. The company issued revenue guidance of $$1.127-1.142 billion, compared to the consensus revenue estimate of $$1.13 billion.

What price target have analysts set for TVTY?

8 analysts have issued 1-year target prices for Tivity Health's stock. Their forecasts range from $22.00 to $40.00. On average, they anticipate Tivity Health's stock price to reach $30.22 in the next twelve months. This suggests a possible upside of 22.9% from the stock's current price. View Analyst Price Targets for Tivity Health.

What is the consensus analysts' recommendation for Tivity Health?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tivity Health in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tivity Health.

What are Wall Street analysts saying about Tivity Health stock?

Here are some recent quotes from research analysts about Tivity Health stock:
  • 1. According to Zacks Investment Research, "Tivity Health, Inc. provides health management services. The company offers services which include chiropractic services, physical therapy, occupational therapy, speech therapy, acupuncture, massage and complementary and alternative medicine services. Its network comprises SilverSneakers(R), Prime(R) Fitness and WholeHealth Living (TM). Tivity Health, Inc., formerly known as Healthways, Inc., is based in Franklin, Tennessee. " (12/24/2019)
  • 2. Chardan Capital analysts commented, "We like the company’s continuing momentum in the healthcare business and successful selling season in Prime Fitness business. We liked Management’s confidence around addressing the Nutrisystem issues. We maintain our Buy rating and lower our 12-month $24 based on lower estimates and the company’s lower trading multiple." (8/23/2019)
  • 3. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating on TVTY shares and maintain our $40 price target. Last month, Tivity completed the acquisition of Nutrisystem, a leading provider of weight management products and services. While the acquisition has been met with investor skepticism, we believe the combination is logical and provides an attractive growth opportunity for TVTY. To better understand the value proposition of the merger, our note includes a detailed overview on the nutrition/weight management industry. Our findings support our view that the combined company should be able to generate significant revenue synergies." (4/22/2019)

Has Tivity Health been receiving favorable news coverage?

News stories about TVTY stock have trended somewhat negative this week, according to InfoTrie. InfoTrie identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Tivity Health earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 7.0 out of 10, meaning that recent news coverage is likely to have an impact on the company's share price in the near future. View News Stories for Tivity Health.

Who are some of Tivity Health's key competitors?

What other stocks do shareholders of Tivity Health own?

Who are Tivity Health's key executives?

Tivity Health's management team includes the folowing people:
  • Mr. Donato J. Tramuto, CEO & Director (Age 62)
  • Mr. Adam C. Holland, Chief Financial Officer (Age 40)
  • Ms. Mary S. Flipse, Chief Legal & Admin. Officer (Age 52)
  • Ms. Dawn M. Zier, Pres, COO & Director (Age 54)
  • Mr. Ryan Wagers, Chief Accounting Officer & Controller (Age 41)

Who are Tivity Health's major shareholders?

Tivity Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Advisors Preferred LLC (0.04%), Campbell & CO Investment Adviser LLC (0.03%), 6 Meridian (0.03%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Tivity Health stock include Bradley S Karro, Donato Tramuto, Ira Sochet and Sara Finley. View Institutional Ownership Trends for Tivity Health.

Which major investors are selling Tivity Health stock?

TVTY stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System. View Insider Buying and Selling for Tivity Health.

Which major investors are buying Tivity Health stock?

TVTY stock was purchased by a variety of institutional investors in the last quarter, including Advisors Preferred LLC, Campbell & CO Investment Adviser LLC and 6 Meridian. Company insiders that have bought Tivity Health stock in the last two years include Bradley S Karro, Ira Sochet and Sara Finley. View Insider Buying and Selling for Tivity Health.

How do I buy shares of Tivity Health?

Shares of TVTY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tivity Health's stock price today?

One share of TVTY stock can currently be purchased for approximately $24.60.

How big of a company is Tivity Health?

Tivity Health has a market capitalization of $1.18 billion and generates $606.30 million in revenue each year. The company earns $98.80 million in net income (profit) each year or $2.34 on an earnings per share basis. Tivity Health employs 500 workers across the globe.View Additional Information About Tivity Health.

What is Tivity Health's official website?

The official website for Tivity Health is http://www.tivityhealth.com/.

How can I contact Tivity Health?

Tivity Health's mailing address is 701 Cool Springs Boulevard, Franklin TN, 37067. The company can be reached via phone at 800-869-5311 or via email at [email protected]


MarketBeat Community Rating for Tivity Health (NASDAQ TVTY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  372 (Vote Outperform)
Underperform Votes:  416 (Vote Underperform)
Total Votes:  788
MarketBeat's community ratings are surveys of what our community members think about Tivity Health and other stocks. Vote "Outperform" if you believe TVTY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TVTY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Featured Article: Why do earnings reports matter?
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel